BJOG Editors’ Disclosures of Interests
Sherif Abdel-Fattah has received a small contribution form Toshiba towards expenses to attend ISUOG international conference in Hamburg on 2009.
Ganesh Acharya is a principal investigator for several studies funded by the Regional Health Authority of Northern Norway.
Hesham Al-Inany received an Honororia for speaking in two symposium sponsored by IBSA in 2003 and 2004. His PhD thesis was partly covered by IBSA and Ferring.
Consultant to Ferring. Advisory Board and honorarium received from Organon, Serono, Shire and Schering. Funding includes Ferring, Serono and Organon. NIAC, Verity, PCOS UK. RCOG involvement: RCOG Committee member and Study Group
Vincenzo Berghella ended his period on the speaker's bureau for Adeza in 2006. He will receive royalties from Informa Healthcare for the books 'Obstetric Evidence Based Guidelines' and 'Maternal-Fetal Evidence Based Guidelines', published in 2007. Cytyc sponsored a chapter signing for these books in 2007. He attended a meeting on progesterone for prevention of preterm birth sponsored by Columbia Laboratories in 2007.
In the last three years Amar Bhide has received grant funding from St. George’s Hospital charitable trust towards conducting research. He has received funding to defray the expenses of attendance at meetings from Deenanath Mangeshkar Hospital and Terna Medical college in India, Royal Jubilee Maternity Hospital, Belfast, the Society of Obstetricians and Gynaecologists of the Netherlands and Ain Shams University, Egypt. He has been treated to dinner while attending a meeting with representatives of GE Healthcare. He has received honorarium for examining at MRCOG courses held at Queen Elizabeth II Hospital and St. George’s Hospital. He has received authors’ royalty of the three books that he has authored.
In the last three years Rufus Cartwright has received speakers honoraria and travel expenses from UCB Pharma and Astellas, who also provided salary and consumables support for previous work contributing to his MD thesis. His post is part funded by the NIHR, and his current research is funded by small grants from the UK Continence Society, the Genesis Research Trust, the International Urogynecological Association, and the Imperial College Healthcare Charity. He sits on editorial boards for both European Urology and Neurourology & Urodynamics.
During the last three years Patrick Chien has received funding from Ferring Pharmaceutical and Hologic UK (formerly Cytyc UK) to attend meetings sponsored by these companies.
- Co-opted member of Scottish Committee of RCOG (SCRCOG)
- Director of Scottish Hydatiform Mole Follow-up service
- Examiner of Part II MRCOG
- SCRCOG deputy representative on Scottish Intercollegiate Guideline Network Council (SIGN)
Member of guideline development group for updating SIGN Guideline 60: Postnatal Depression and Puerperal Psychosis
Financial: Justin Clark is a Consultant to Conceptus. He received an honoraria from Hologic and Ethicon for clinician training which has been paid into a charitable account to fund research. He has also received an honoraria for lecturing from Nordic Pharma. He has received trial funding from Hologic and is currently a member of their European Advisory Board. He has received funding for travel and accommodation at national and international conferences from Ethicon, Hologic and Conceptus.
Non-financial: He receives research funding from the Department of Health, he is HTA Programme Elected West-Midlands member and a member of the RCOG council.
Emma Crosbie has received funding from the NIHR, Cancer Research UK, University of Manchester, Joseph Starkey Clinical Research Fund and other charitable funding streams. She was paid a small honorarium to serve as an advisor on HPV vaccines for GSK in 2010 and was sponsored by GSK to attend the EUROGIN and International HPV conferences in 2011.
During the last three years Stergios K. Doumouchtsis has received sponsorship by Astellas and Pfizer for participation in meetings and conferences.
Donald Dudley has no ‘disclosure of interests’ to report.
Tarek El-Toukhy invited in 2007 to attend ESHRE conference in Lyon by a Serono pharmaceuticals.
Vanessa has received funding from NHS Research and Development Department at Aberdeen Royal Infirmary to cover the cost of research/functional MRI examinations.
Professor Khalid Khan's research is largely funded by public bodies in the UK and European Union. He has participated in research projects where pharmaceuticals (e.g. Ferring Pharmaceuticals) have contributed a grant. He has received honoraria and has had travel/accommodation expenses covered/reimbursed for speaking at meetings from pharmaceuticals (e.g. Ferring Pharmaceuticals) and from various Colleges, Universities and Societies. He receives royalties on his books from publishers (Hodder Arnold; Huber). His institution has received sponsorship for organising educational meetings (Alere; Ethicon; Ferring Pharmaceuticals; Hologic; Leo-Pharma; Preglem/Quintiles; Viforpharma). He is a partner in a Partnership where he offers advice on several matters including matters within medical research and negligence. He provides expert reports in medical negligence cases for which fee is paid by instructing solicitors. (Updated: April 2012)
Over the last year Mike Marsh has been a member of the Lambeth, Southwark and Lewisham Joint Formulary Committee, a member/ chair of the CEMACH mental health in pregnancy review panel and a member of the King's College Hospital Assisted Conception Ethics Committee, for which he receives no fee. He receives remuneration as an Associate and reviewer for the Healthcare Commission, as an undergraduate and postgraduate examiner within the University of London, and from book sales. He is part of a research group that received a Pathfinder grant from the MRC of £160,000 for a study exploring the gestational cortisol axis in depressed and healthy pregnant women.
In the last three years, he has attended meetings organised by GSK and Sanofi Pasteur. I have no other competing interests.
Shanthi Muttukrishna is an academic researcher with an interest in biomarkers in predicting pregnancy complications and ovarian aging. Research was funded by Wellcome trust, National science foundation (USA) and British Council.
In the last three years, she has presented at meetings as an invited speaker where the expenses were reimbursed by the society or sponsor.
Jenny Myers peforms consultancy work for Pronota and Alere in research relating to pre-eclampsia prediction. Her research has been partially funded by Tommy’s Baby Charity.
Raj Naik has acted as an advisory board member for Sanofi Pasteur MSD. He has also given sponsored presentations for Baxter Healthcare Ltd. He is a recognised trainer for the DySIS colposcope. He is also on the Roche Medical Advisory Committee for Bevacizumab.
During the last three years Aris T Papageorghiou has spoken in meetings which were financially supported by Philips and Siemens. He has received funding as invited faculty by the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) for attending the 16th World Congress, and has been invited for dinner by ISUOG and GE. He has not received honoraria from these organisations.
During the last three years Federico Prefumo has received funding to support speaking at meetings from the Italian Society for Ultrasound in Obstetrics and Gynaecology, the International Society of Ultrasound in Obstetrics and Gynecology, the Turkish Gynecology and Obstetrics Association, the Italian Association of Hospital Obstetricians and Gynaecologists, the Dutch Society of Obstetrics and Gynaecology, the Burlo Garofolo Scientific Institute in Trieste, the University of Naples, the European Association of Perinatal Medicine, Sofar Pharmaceuticals. He has spoken in meetings which were financially supported by Philips and Bayer Schering.
Limbs&Things have taken Dimitrios Siassakos to dinner and have agreed to sponsor lunch for the course he organises once per year (SMASH: Saving Mothers with Advanced Simulation of High-risk situations). Ferring have piad his expenses to attend a Clinical Expert meeting in 2011. He is a registered member of the PROMPT Maternity Foundation, a UK-based charity.
During the last eight years Philip Steer has received funding and honoraria to support speaking at meetings from Ferring Pharmaceuticals, Alliance Medical, Pfizer, Milupa, the Obstetric Anaesthetist’s Association, the North Midlands Urogynaecological Society, Postgraduate Education and Academic Affairs Department National Guard Health Affairs Riyadh Saudi Arabia, and BabyLifeline. FIGO (speakers honorarium), Bristol Hospitals Healthcare Trust, the Icelandic Medical Association, the 3rd Military Hospital Chonqing, AsiaPacific Congress of Fetal/Maternal Medicine, the British Maternal and Fetal Medicine Society, the British Association of Perinatal Medicine, the European Congress of Perinatal Medicine, the Swedish Society of Obstetricians and Gynaecologists, the National Perinatal Society of Jordan, the National Perinatal Society of Turkey, the RCOG, the International Association for Adult Congenital Heart Disease, the World Association of Perinatal Medicine, the Japanese Society for Congenital Heart disease and the Universities of Cape Town, Rome, Zurich, Leuven, Uppsala, Copenhagen, Leeds, Nottingham and Cambridge. He has received travel expenses and honoraria for examining from the Universities of Hong Kong, Lund and Stockholm. He has been treated to dinner while attending a meeting with representatives of Hewlett Packard Ltd. to discuss fetal monitoring. He has received fees for medicolegal opinions/ consultancy from the Welsh Health Legal Authority, Northwick Park Hospitals NHS Trust, Newham University Hospital, Her Majesty’s Police and various solicitors. He receives publication royalties from Elsevier, and ALCS. He chairs the medical advisory panel of ‘Group B Strep Support’ (unpaid). His research is funded by public bodies in the UK (including the HTA).
1. Chairman of the research subcommittee of British Society of Urogynaecology
2. A member of the Wellbeing of Women Research Advisory Committee
3. A member of the RCOG Scientific Advisory Committee
4. A member of NIHR Programme Grants for Applied Research College Experts
Dr Tincello is principal investigator on several clinical trials, funder by research councils, charities, or self funded:
1. Colposuspension or TVT with anterior repair for urinary incontinence and prolapse: a pilot study (CARPET 1). EUDRaCT number: 2006-001809; ISRCTN number: ISRCTN34759911. Funded by MRC.
2. Randomised trial of botulinum toxin A versus placebo for refractory detrusor overactivity (RELAX). EUDRaCT number: 2004-002981-39; ISRCTN number: ISRCTN26091555. Funded by Wellbeing of Women & The Moulton Charitable Trust; drugs provided by Allergan.
3. BUPA Foundation. Evaluation of diet and lifestyle, comorbidity and socio-economic factors in the aetiology of urinary storage disorder in women. McGrother C, Tincello DG, Wagg A. £104, 120
Dr Tincello has been in the following industry funded studies, as investigator and/or advisory board member:
1. Stress Urinary Incontinence Treatment (SUIT) study: a cost effectiveness study of conservative treatments for incontinence: funded by Eli Lilly & Co.
2. TVT-Worldwide Observational Registry for Long-term Data (TVT-WORLD) Study: funded by Ethicon Inc. (Johnson & Johnson Medical).
Consultancy payments for these studies have been managed by the University of Leicester Research and Business Office and used to support Dr Tincello's research programme.
John Thorp has received consulting fees and honoraria from Adeza Biomedical, PPD Pharmaceuticals,and Glaxo Smith Kline.
Austin Ugwumadu has received honoraria for speaking at meetings from SMA Nutrition, British Maternal and Fetal Medicine Society, conducting study days on intrapartum care and fetal monitoring in various hospital trusts, and for examining Doctorate and Masters Theses from the Universities of London, Brighton and Kwazulu Natal, Durban South Africa. He has also received funding to offset the expenses of attendance at meetings from the WHO, FIGO, European Association of Perinatal Medicine, Gulf Congress of Obstetrics & Gynaecology, and European Society for Infectious Diseases in Obstetrics & gynaecology. He has received fees for medicolegal opinions from NHS Hospital Trusts and various solicitors.
Professor Witkin is a member of a National Institute of Health Obstetrics and Maternal-Fetal Biology Study Section and is also a member of the advisory board of the National Vulvodynia Association. Professor Witkin is a member of the editorial board for a number of journals, namely: the Journal of Reproductive Immunology, Journal of the Hungarian STD Society, Jornal Brasileiro de Doenças Sexualmente Transmissíveis, Italian Journal of Gynecology and Obstetrics, and Cell Stress and Chaperones.
Professor Witkin was an editor of the BJOG 2011 themed issue on Infections in Pregnancy. To view and download this special issue click here
Matthew Barber receives research grant support from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and from the Foundation for Female Health Awareness. He receives royalty payments from Elsevier for the book ‘Hysterectomy for Benign Disease’ published in 2010 and from UpToDate for providing educational content.